nodes	percent_of_prediction	percent_of_DWPC	metapath
Naratriptan—Sumatriptan—SLCO1B1—breast cancer	0.00442	0.341	CrCbGaD
Naratriptan—Sumatriptan—ABCG2—breast cancer	0.00192	0.148	CrCbGaD
Naratriptan—Eletriptan—PTGS1—breast cancer	0.00133	0.103	CrCbGaD
Naratriptan—Almotriptan—CYP2D6—breast cancer	0.00116	0.0898	CrCbGaD
Naratriptan—Almotriptan—CYP3A4—breast cancer	0.000998	0.077	CrCbGaD
Naratriptan—Eletriptan—CYP2D6—breast cancer	0.000907	0.0699	CrCbGaD
Naratriptan—Sumatriptan—ABCB1—breast cancer	0.0008	0.0617	CrCbGaD
Naratriptan—Eletriptan—CYP3A4—breast cancer	0.000778	0.06	CrCbGaD
Naratriptan—Eletriptan—ABCB1—breast cancer	0.000648	0.0499	CrCbGaD
Naratriptan—Infection—Capecitabine—breast cancer	0.000159	0.000206	CcSEcCtD
Naratriptan—Neuropathy peripheral—Doxorubicin—breast cancer	0.000158	0.000206	CcSEcCtD
Naratriptan—Dizziness—Irinotecan—breast cancer	0.000158	0.000205	CcSEcCtD
Naratriptan—Haemoglobin—Epirubicin—breast cancer	0.000158	0.000205	CcSEcCtD
Naratriptan—Shock—Capecitabine—breast cancer	0.000157	0.000204	CcSEcCtD
Naratriptan—Nervous system disorder—Capecitabine—breast cancer	0.000157	0.000204	CcSEcCtD
Naratriptan—Haemorrhage—Epirubicin—breast cancer	0.000157	0.000204	CcSEcCtD
Naratriptan—Diarrhoea—Fluorouracil—breast cancer	0.000157	0.000203	CcSEcCtD
Naratriptan—Thrombocytopenia—Capecitabine—breast cancer	0.000157	0.000203	CcSEcCtD
Naratriptan—Tinnitus—Methotrexate—breast cancer	0.000156	0.000203	CcSEcCtD
Naratriptan—Hypoaesthesia—Epirubicin—breast cancer	0.000156	0.000203	CcSEcCtD
Naratriptan—Cardiac disorder—Methotrexate—breast cancer	0.000155	0.000202	CcSEcCtD
Naratriptan—Skin disorder—Capecitabine—breast cancer	0.000155	0.000202	CcSEcCtD
Naratriptan—Sweating—Doxorubicin—breast cancer	0.000155	0.000201	CcSEcCtD
Naratriptan—Urticaria—Paclitaxel—breast cancer	0.000155	0.000201	CcSEcCtD
Naratriptan—Hyperhidrosis—Capecitabine—breast cancer	0.000155	0.000201	CcSEcCtD
Naratriptan—Hypotension—Docetaxel—breast cancer	0.000154	0.0002	CcSEcCtD
Naratriptan—Body temperature increased—Paclitaxel—breast cancer	0.000154	0.0002	CcSEcCtD
Naratriptan—Angiopathy—Methotrexate—breast cancer	0.000152	0.000197	CcSEcCtD
Naratriptan—Vomiting—Irinotecan—breast cancer	0.000152	0.000197	CcSEcCtD
Naratriptan—Vomiting—Mitoxantrone—breast cancer	0.000152	0.000197	CcSEcCtD
Naratriptan—Sinusitis—Doxorubicin—breast cancer	0.000152	0.000197	CcSEcCtD
Naratriptan—Immune system disorder—Methotrexate—breast cancer	0.000151	0.000197	CcSEcCtD
Naratriptan—Dizziness—Fluorouracil—breast cancer	0.000151	0.000197	CcSEcCtD
Naratriptan—Rash—Mitoxantrone—breast cancer	0.000151	0.000196	CcSEcCtD
Naratriptan—Rash—Irinotecan—breast cancer	0.000151	0.000196	CcSEcCtD
Naratriptan—Dermatitis—Irinotecan—breast cancer	0.00015	0.000195	CcSEcCtD
Naratriptan—Dermatitis—Mitoxantrone—breast cancer	0.00015	0.000195	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Docetaxel—breast cancer	0.00015	0.000195	CcSEcCtD
Naratriptan—Chills—Methotrexate—breast cancer	0.00015	0.000195	CcSEcCtD
Naratriptan—Headache—Mitoxantrone—breast cancer	0.00015	0.000194	CcSEcCtD
Naratriptan—Headache—Irinotecan—breast cancer	0.00015	0.000194	CcSEcCtD
Naratriptan—Hypotension—Capecitabine—breast cancer	0.000149	0.000194	CcSEcCtD
Naratriptan—Paraesthesia—Docetaxel—breast cancer	0.000148	0.000193	CcSEcCtD
Naratriptan—Alopecia—Methotrexate—breast cancer	0.000148	0.000192	CcSEcCtD
Naratriptan—Vomiting—Gemcitabine—breast cancer	0.000148	0.000192	CcSEcCtD
Naratriptan—Bradycardia—Doxorubicin—breast cancer	0.000148	0.000192	CcSEcCtD
Naratriptan—Dyspnoea—Docetaxel—breast cancer	0.000147	0.000191	CcSEcCtD
Naratriptan—Somnolence—Docetaxel—breast cancer	0.000147	0.000191	CcSEcCtD
Naratriptan—Rash—Gemcitabine—breast cancer	0.000147	0.000191	CcSEcCtD
Naratriptan—Dermatitis—Gemcitabine—breast cancer	0.000147	0.00019	CcSEcCtD
Naratriptan—Tinnitus—Epirubicin—breast cancer	0.000146	0.00019	CcSEcCtD
Naratriptan—Erythema—Methotrexate—breast cancer	0.000146	0.000189	CcSEcCtD
Naratriptan—Haemoglobin—Doxorubicin—breast cancer	0.000146	0.000189	CcSEcCtD
Naratriptan—Headache—Gemcitabine—breast cancer	0.000146	0.000189	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Capecitabine—breast cancer	0.000146	0.000189	CcSEcCtD
Naratriptan—Cardiac disorder—Epirubicin—breast cancer	0.000145	0.000189	CcSEcCtD
Naratriptan—Vomiting—Fluorouracil—breast cancer	0.000145	0.000189	CcSEcCtD
Naratriptan—Haemorrhage—Doxorubicin—breast cancer	0.000145	0.000188	CcSEcCtD
Naratriptan—Hypoaesthesia—Doxorubicin—breast cancer	0.000144	0.000187	CcSEcCtD
Naratriptan—Rash—Fluorouracil—breast cancer	0.000144	0.000187	CcSEcCtD
Naratriptan—Dermatitis—Fluorouracil—breast cancer	0.000144	0.000187	CcSEcCtD
Naratriptan—Paraesthesia—Capecitabine—breast cancer	0.000144	0.000186	CcSEcCtD
Naratriptan—Hypersensitivity—Paclitaxel—breast cancer	0.000144	0.000186	CcSEcCtD
Naratriptan—Headache—Fluorouracil—breast cancer	0.000143	0.000186	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Docetaxel—breast cancer	0.000143	0.000185	CcSEcCtD
Naratriptan—Dyspnoea—Capecitabine—breast cancer	0.000143	0.000185	CcSEcCtD
Naratriptan—Fatigue—Docetaxel—breast cancer	0.000142	0.000185	CcSEcCtD
Naratriptan—Angiopathy—Epirubicin—breast cancer	0.000142	0.000185	CcSEcCtD
Naratriptan—Nausea—Mitoxantrone—breast cancer	0.000142	0.000184	CcSEcCtD
Naratriptan—Nausea—Irinotecan—breast cancer	0.000142	0.000184	CcSEcCtD
Naratriptan—Immune system disorder—Epirubicin—breast cancer	0.000142	0.000184	CcSEcCtD
Naratriptan—Pain—Docetaxel—breast cancer	0.000141	0.000183	CcSEcCtD
Naratriptan—Constipation—Docetaxel—breast cancer	0.000141	0.000183	CcSEcCtD
Naratriptan—Chills—Epirubicin—breast cancer	0.000141	0.000183	CcSEcCtD
Naratriptan—Arrhythmia—Epirubicin—breast cancer	0.00014	0.000182	CcSEcCtD
Naratriptan—Asthenia—Paclitaxel—breast cancer	0.00014	0.000182	CcSEcCtD
Naratriptan—Alopecia—Epirubicin—breast cancer	0.000139	0.00018	CcSEcCtD
Naratriptan—Nausea—Gemcitabine—breast cancer	0.000138	0.00018	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Capecitabine—breast cancer	0.000138	0.000179	CcSEcCtD
Naratriptan—Fatigue—Capecitabine—breast cancer	0.000138	0.000179	CcSEcCtD
Naratriptan—Pruritus—Paclitaxel—breast cancer	0.000138	0.000179	CcSEcCtD
Naratriptan—Vision blurred—Methotrexate—breast cancer	0.000137	0.000179	CcSEcCtD
Naratriptan—Constipation—Capecitabine—breast cancer	0.000137	0.000178	CcSEcCtD
Naratriptan—Pain—Capecitabine—breast cancer	0.000137	0.000178	CcSEcCtD
Naratriptan—Erythema—Epirubicin—breast cancer	0.000136	0.000177	CcSEcCtD
Naratriptan—Feeling abnormal—Docetaxel—breast cancer	0.000136	0.000177	CcSEcCtD
Naratriptan—Nausea—Fluorouracil—breast cancer	0.000136	0.000177	CcSEcCtD
Naratriptan—Ill-defined disorder—Methotrexate—breast cancer	0.000135	0.000176	CcSEcCtD
Naratriptan—Tinnitus—Doxorubicin—breast cancer	0.000135	0.000176	CcSEcCtD
Naratriptan—Anaemia—Methotrexate—breast cancer	0.000135	0.000175	CcSEcCtD
Naratriptan—Cardiac disorder—Doxorubicin—breast cancer	0.000135	0.000175	CcSEcCtD
Naratriptan—Diarrhoea—Paclitaxel—breast cancer	0.000133	0.000173	CcSEcCtD
Naratriptan—Feeling abnormal—Capecitabine—breast cancer	0.000132	0.000171	CcSEcCtD
Naratriptan—Angiopathy—Doxorubicin—breast cancer	0.000132	0.000171	CcSEcCtD
Naratriptan—Malaise—Methotrexate—breast cancer	0.000132	0.000171	CcSEcCtD
Naratriptan—Muscle spasms—Epirubicin—breast cancer	0.000131	0.00017	CcSEcCtD
Naratriptan—Immune system disorder—Doxorubicin—breast cancer	0.000131	0.00017	CcSEcCtD
Naratriptan—Vertigo—Methotrexate—breast cancer	0.000131	0.00017	CcSEcCtD
Naratriptan—Body temperature increased—Docetaxel—breast cancer	0.000131	0.00017	CcSEcCtD
Naratriptan—Chills—Doxorubicin—breast cancer	0.00013	0.000169	CcSEcCtD
Naratriptan—Arrhythmia—Doxorubicin—breast cancer	0.00013	0.000168	CcSEcCtD
Naratriptan—Dizziness—Paclitaxel—breast cancer	0.000129	0.000167	CcSEcCtD
Naratriptan—Vision blurred—Epirubicin—breast cancer	0.000129	0.000167	CcSEcCtD
Naratriptan—Alopecia—Doxorubicin—breast cancer	0.000128	0.000167	CcSEcCtD
Naratriptan—Cough—Methotrexate—breast cancer	0.000127	0.000165	CcSEcCtD
Naratriptan—Urticaria—Capecitabine—breast cancer	0.000127	0.000165	CcSEcCtD
Naratriptan—Ill-defined disorder—Epirubicin—breast cancer	0.000127	0.000164	CcSEcCtD
Naratriptan—Body temperature increased—Capecitabine—breast cancer	0.000126	0.000164	CcSEcCtD
Naratriptan—Convulsion—Methotrexate—breast cancer	0.000126	0.000164	CcSEcCtD
Naratriptan—Erythema—Doxorubicin—breast cancer	0.000126	0.000164	CcSEcCtD
Naratriptan—Anaemia—Epirubicin—breast cancer	0.000126	0.000164	CcSEcCtD
Naratriptan—Agitation—Epirubicin—breast cancer	0.000125	0.000163	CcSEcCtD
Naratriptan—Myalgia—Methotrexate—breast cancer	0.000124	0.000161	CcSEcCtD
Naratriptan—Arthralgia—Methotrexate—breast cancer	0.000124	0.000161	CcSEcCtD
Naratriptan—Vomiting—Paclitaxel—breast cancer	0.000124	0.000161	CcSEcCtD
Naratriptan—Malaise—Epirubicin—breast cancer	0.000123	0.00016	CcSEcCtD
Naratriptan—Rash—Paclitaxel—breast cancer	0.000123	0.00016	CcSEcCtD
Naratriptan—Dermatitis—Paclitaxel—breast cancer	0.000123	0.000159	CcSEcCtD
Naratriptan—Discomfort—Methotrexate—breast cancer	0.000123	0.000159	CcSEcCtD
Naratriptan—Vertigo—Epirubicin—breast cancer	0.000123	0.000159	CcSEcCtD
Naratriptan—Syncope—Epirubicin—breast cancer	0.000122	0.000159	CcSEcCtD
Naratriptan—Headache—Paclitaxel—breast cancer	0.000122	0.000159	CcSEcCtD
Naratriptan—Hypersensitivity—Docetaxel—breast cancer	0.000122	0.000158	CcSEcCtD
Naratriptan—Muscle spasms—Doxorubicin—breast cancer	0.000121	0.000158	CcSEcCtD
Naratriptan—Palpitations—Epirubicin—breast cancer	0.000121	0.000157	CcSEcCtD
Naratriptan—Confusional state—Methotrexate—breast cancer	0.00012	0.000156	CcSEcCtD
Naratriptan—Loss of consciousness—Epirubicin—breast cancer	0.00012	0.000156	CcSEcCtD
Naratriptan—Cough—Epirubicin—breast cancer	0.000119	0.000155	CcSEcCtD
Naratriptan—Anaphylactic shock—Methotrexate—breast cancer	0.000119	0.000155	CcSEcCtD
Naratriptan—Vision blurred—Doxorubicin—breast cancer	0.000119	0.000155	CcSEcCtD
Naratriptan—Asthenia—Docetaxel—breast cancer	0.000118	0.000154	CcSEcCtD
Naratriptan—Convulsion—Epirubicin—breast cancer	0.000118	0.000154	CcSEcCtD
Naratriptan—Infection—Methotrexate—breast cancer	0.000118	0.000154	CcSEcCtD
Naratriptan—Hypersensitivity—Capecitabine—breast cancer	0.000118	0.000153	CcSEcCtD
Naratriptan—Ill-defined disorder—Doxorubicin—breast cancer	0.000117	0.000152	CcSEcCtD
Naratriptan—Pruritus—Docetaxel—breast cancer	0.000117	0.000152	CcSEcCtD
Naratriptan—Nervous system disorder—Methotrexate—breast cancer	0.000117	0.000152	CcSEcCtD
Naratriptan—Anaemia—Doxorubicin—breast cancer	0.000117	0.000152	CcSEcCtD
Naratriptan—Thrombocytopenia—Methotrexate—breast cancer	0.000117	0.000151	CcSEcCtD
Naratriptan—Arthralgia—Epirubicin—breast cancer	0.000116	0.000151	CcSEcCtD
Naratriptan—Myalgia—Epirubicin—breast cancer	0.000116	0.000151	CcSEcCtD
Naratriptan—Agitation—Doxorubicin—breast cancer	0.000116	0.000151	CcSEcCtD
Naratriptan—Anxiety—Epirubicin—breast cancer	0.000116	0.00015	CcSEcCtD
Naratriptan—Nausea—Paclitaxel—breast cancer	0.000116	0.00015	CcSEcCtD
Naratriptan—Skin disorder—Methotrexate—breast cancer	0.000116	0.00015	CcSEcCtD
Naratriptan—Hyperhidrosis—Methotrexate—breast cancer	0.000115	0.000149	CcSEcCtD
Naratriptan—Discomfort—Epirubicin—breast cancer	0.000115	0.000149	CcSEcCtD
Naratriptan—Asthenia—Capecitabine—breast cancer	0.000115	0.000149	CcSEcCtD
Naratriptan—Malaise—Doxorubicin—breast cancer	0.000114	0.000148	CcSEcCtD
Naratriptan—Dry mouth—Epirubicin—breast cancer	0.000114	0.000148	CcSEcCtD
Naratriptan—Vertigo—Doxorubicin—breast cancer	0.000113	0.000147	CcSEcCtD
Naratriptan—Syncope—Doxorubicin—breast cancer	0.000113	0.000147	CcSEcCtD
Naratriptan—Pruritus—Capecitabine—breast cancer	0.000113	0.000147	CcSEcCtD
Naratriptan—Diarrhoea—Docetaxel—breast cancer	0.000113	0.000147	CcSEcCtD
Naratriptan—Confusional state—Epirubicin—breast cancer	0.000112	0.000146	CcSEcCtD
Naratriptan—Palpitations—Doxorubicin—breast cancer	0.000112	0.000145	CcSEcCtD
Naratriptan—Oedema—Epirubicin—breast cancer	0.000111	0.000145	CcSEcCtD
Naratriptan—Anaphylactic shock—Epirubicin—breast cancer	0.000111	0.000145	CcSEcCtD
Naratriptan—Hypotension—Methotrexate—breast cancer	0.000111	0.000144	CcSEcCtD
Naratriptan—Loss of consciousness—Doxorubicin—breast cancer	0.000111	0.000144	CcSEcCtD
Naratriptan—Infection—Epirubicin—breast cancer	0.000111	0.000144	CcSEcCtD
Naratriptan—Cough—Doxorubicin—breast cancer	0.00011	0.000143	CcSEcCtD
Naratriptan—Shock—Epirubicin—breast cancer	0.00011	0.000142	CcSEcCtD
Naratriptan—Convulsion—Doxorubicin—breast cancer	0.000109	0.000142	CcSEcCtD
Naratriptan—Diarrhoea—Capecitabine—breast cancer	0.000109	0.000142	CcSEcCtD
Naratriptan—Nervous system disorder—Epirubicin—breast cancer	0.000109	0.000142	CcSEcCtD
Naratriptan—Dizziness—Docetaxel—breast cancer	0.000109	0.000142	CcSEcCtD
Naratriptan—Thrombocytopenia—Epirubicin—breast cancer	0.000109	0.000142	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Methotrexate—breast cancer	0.000108	0.000141	CcSEcCtD
Naratriptan—Skin disorder—Epirubicin—breast cancer	0.000108	0.000141	CcSEcCtD
Naratriptan—Hyperhidrosis—Epirubicin—breast cancer	0.000108	0.00014	CcSEcCtD
Naratriptan—Myalgia—Doxorubicin—breast cancer	0.000108	0.00014	CcSEcCtD
Naratriptan—Arthralgia—Doxorubicin—breast cancer	0.000108	0.00014	CcSEcCtD
Naratriptan—Anxiety—Doxorubicin—breast cancer	0.000107	0.000139	CcSEcCtD
Naratriptan—Paraesthesia—Methotrexate—breast cancer	0.000107	0.000139	CcSEcCtD
Naratriptan—Discomfort—Doxorubicin—breast cancer	0.000106	0.000138	CcSEcCtD
Naratriptan—Dyspnoea—Methotrexate—breast cancer	0.000106	0.000138	CcSEcCtD
Naratriptan—Somnolence—Methotrexate—breast cancer	0.000106	0.000137	CcSEcCtD
Naratriptan—Dizziness—Capecitabine—breast cancer	0.000106	0.000137	CcSEcCtD
Naratriptan—Dry mouth—Doxorubicin—breast cancer	0.000105	0.000137	CcSEcCtD
Naratriptan—Vomiting—Docetaxel—breast cancer	0.000105	0.000136	CcSEcCtD
Naratriptan—Rash—Docetaxel—breast cancer	0.000104	0.000135	CcSEcCtD
Naratriptan—Hypotension—Epirubicin—breast cancer	0.000104	0.000135	CcSEcCtD
Naratriptan—Dermatitis—Docetaxel—breast cancer	0.000104	0.000135	CcSEcCtD
Naratriptan—Confusional state—Doxorubicin—breast cancer	0.000104	0.000135	CcSEcCtD
Naratriptan—Headache—Docetaxel—breast cancer	0.000103	0.000134	CcSEcCtD
Naratriptan—Anaphylactic shock—Doxorubicin—breast cancer	0.000103	0.000134	CcSEcCtD
Naratriptan—Oedema—Doxorubicin—breast cancer	0.000103	0.000134	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Methotrexate—breast cancer	0.000103	0.000133	CcSEcCtD
Naratriptan—Fatigue—Methotrexate—breast cancer	0.000103	0.000133	CcSEcCtD
Naratriptan—Infection—Doxorubicin—breast cancer	0.000102	0.000133	CcSEcCtD
Naratriptan—Pain—Methotrexate—breast cancer	0.000102	0.000132	CcSEcCtD
Naratriptan—Vomiting—Capecitabine—breast cancer	0.000102	0.000132	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Epirubicin—breast cancer	0.000101	0.000132	CcSEcCtD
Naratriptan—Shock—Doxorubicin—breast cancer	0.000101	0.000132	CcSEcCtD
Naratriptan—Nervous system disorder—Doxorubicin—breast cancer	0.000101	0.000131	CcSEcCtD
Naratriptan—Thrombocytopenia—Doxorubicin—breast cancer	0.000101	0.000131	CcSEcCtD
Naratriptan—Rash—Capecitabine—breast cancer	0.000101	0.000131	CcSEcCtD
Naratriptan—Dermatitis—Capecitabine—breast cancer	0.000101	0.000131	CcSEcCtD
Naratriptan—Headache—Capecitabine—breast cancer	0.0001	0.00013	CcSEcCtD
Naratriptan—Skin disorder—Doxorubicin—breast cancer	0.0001	0.00013	CcSEcCtD
Naratriptan—Paraesthesia—Epirubicin—breast cancer	0.0001	0.00013	CcSEcCtD
Naratriptan—Hyperhidrosis—Doxorubicin—breast cancer	9.96e-05	0.000129	CcSEcCtD
Naratriptan—Dyspnoea—Epirubicin—breast cancer	9.93e-05	0.000129	CcSEcCtD
Naratriptan—Somnolence—Epirubicin—breast cancer	9.9e-05	0.000129	CcSEcCtD
Naratriptan—Nausea—Docetaxel—breast cancer	9.81e-05	0.000127	CcSEcCtD
Naratriptan—Feeling abnormal—Methotrexate—breast cancer	9.81e-05	0.000127	CcSEcCtD
Naratriptan—Hypotension—Doxorubicin—breast cancer	9.63e-05	0.000125	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Epirubicin—breast cancer	9.62e-05	0.000125	CcSEcCtD
Naratriptan—Fatigue—Epirubicin—breast cancer	9.6e-05	0.000125	CcSEcCtD
Naratriptan—Pain—Epirubicin—breast cancer	9.52e-05	0.000124	CcSEcCtD
Naratriptan—Constipation—Epirubicin—breast cancer	9.52e-05	0.000124	CcSEcCtD
Naratriptan—Nausea—Capecitabine—breast cancer	9.5e-05	0.000123	CcSEcCtD
Naratriptan—Urticaria—Methotrexate—breast cancer	9.45e-05	0.000123	CcSEcCtD
Naratriptan—Body temperature increased—Methotrexate—breast cancer	9.41e-05	0.000122	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Doxorubicin—breast cancer	9.39e-05	0.000122	CcSEcCtD
Naratriptan—Paraesthesia—Doxorubicin—breast cancer	9.25e-05	0.00012	CcSEcCtD
Naratriptan—Dyspnoea—Doxorubicin—breast cancer	9.19e-05	0.000119	CcSEcCtD
Naratriptan—Feeling abnormal—Epirubicin—breast cancer	9.18e-05	0.000119	CcSEcCtD
Naratriptan—Somnolence—Doxorubicin—breast cancer	9.16e-05	0.000119	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Doxorubicin—breast cancer	8.9e-05	0.000116	CcSEcCtD
Naratriptan—Fatigue—Doxorubicin—breast cancer	8.89e-05	0.000115	CcSEcCtD
Naratriptan—Urticaria—Epirubicin—breast cancer	8.85e-05	0.000115	CcSEcCtD
Naratriptan—Pain—Doxorubicin—breast cancer	8.81e-05	0.000114	CcSEcCtD
Naratriptan—Constipation—Doxorubicin—breast cancer	8.81e-05	0.000114	CcSEcCtD
Naratriptan—Body temperature increased—Epirubicin—breast cancer	8.8e-05	0.000114	CcSEcCtD
Naratriptan—Hypersensitivity—Methotrexate—breast cancer	8.77e-05	0.000114	CcSEcCtD
Naratriptan—Asthenia—Methotrexate—breast cancer	8.54e-05	0.000111	CcSEcCtD
Naratriptan—Feeling abnormal—Doxorubicin—breast cancer	8.49e-05	0.00011	CcSEcCtD
Naratriptan—Pruritus—Methotrexate—breast cancer	8.42e-05	0.000109	CcSEcCtD
Naratriptan—Hypersensitivity—Epirubicin—breast cancer	8.21e-05	0.000107	CcSEcCtD
Naratriptan—Urticaria—Doxorubicin—breast cancer	8.19e-05	0.000106	CcSEcCtD
Naratriptan—Body temperature increased—Doxorubicin—breast cancer	8.15e-05	0.000106	CcSEcCtD
Naratriptan—Diarrhoea—Methotrexate—breast cancer	8.14e-05	0.000106	CcSEcCtD
Naratriptan—Asthenia—Epirubicin—breast cancer	7.99e-05	0.000104	CcSEcCtD
Naratriptan—Pruritus—Epirubicin—breast cancer	7.88e-05	0.000102	CcSEcCtD
Naratriptan—Dizziness—Methotrexate—breast cancer	7.87e-05	0.000102	CcSEcCtD
Naratriptan—Diarrhoea—Epirubicin—breast cancer	7.62e-05	9.9e-05	CcSEcCtD
Naratriptan—Hypersensitivity—Doxorubicin—breast cancer	7.59e-05	9.86e-05	CcSEcCtD
Naratriptan—Vomiting—Methotrexate—breast cancer	7.57e-05	9.83e-05	CcSEcCtD
Naratriptan—Rash—Methotrexate—breast cancer	7.5e-05	9.75e-05	CcSEcCtD
Naratriptan—Dermatitis—Methotrexate—breast cancer	7.5e-05	9.74e-05	CcSEcCtD
Naratriptan—Headache—Methotrexate—breast cancer	7.46e-05	9.69e-05	CcSEcCtD
Naratriptan—Asthenia—Doxorubicin—breast cancer	7.39e-05	9.61e-05	CcSEcCtD
Naratriptan—Dizziness—Epirubicin—breast cancer	7.37e-05	9.57e-05	CcSEcCtD
Naratriptan—Pruritus—Doxorubicin—breast cancer	7.29e-05	9.47e-05	CcSEcCtD
Naratriptan—Vomiting—Epirubicin—breast cancer	7.08e-05	9.2e-05	CcSEcCtD
Naratriptan—Nausea—Methotrexate—breast cancer	7.07e-05	9.18e-05	CcSEcCtD
Naratriptan—Diarrhoea—Doxorubicin—breast cancer	7.05e-05	9.16e-05	CcSEcCtD
Naratriptan—Rash—Epirubicin—breast cancer	7.02e-05	9.12e-05	CcSEcCtD
Naratriptan—Dermatitis—Epirubicin—breast cancer	7.02e-05	9.11e-05	CcSEcCtD
Naratriptan—Headache—Epirubicin—breast cancer	6.98e-05	9.06e-05	CcSEcCtD
Naratriptan—Dizziness—Doxorubicin—breast cancer	6.81e-05	8.85e-05	CcSEcCtD
Naratriptan—Nausea—Epirubicin—breast cancer	6.62e-05	8.59e-05	CcSEcCtD
Naratriptan—Vomiting—Doxorubicin—breast cancer	6.55e-05	8.51e-05	CcSEcCtD
Naratriptan—Rash—Doxorubicin—breast cancer	6.5e-05	8.44e-05	CcSEcCtD
Naratriptan—Dermatitis—Doxorubicin—breast cancer	6.49e-05	8.43e-05	CcSEcCtD
Naratriptan—Headache—Doxorubicin—breast cancer	6.46e-05	8.39e-05	CcSEcCtD
Naratriptan—Nausea—Doxorubicin—breast cancer	6.12e-05	7.95e-05	CcSEcCtD
Naratriptan—HTR1F—Signaling Pathways—PIK3CB—breast cancer	3.19e-05	0.000147	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—IL2—breast cancer	3.18e-05	0.000146	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—TERT—breast cancer	3.16e-05	0.000146	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—STK11—breast cancer	3.15e-05	0.000145	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—ADAM10—breast cancer	3.15e-05	0.000145	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PLG—breast cancer	3.11e-05	0.000143	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—IL2—breast cancer	3.11e-05	0.000143	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—TERT—breast cancer	3.1e-05	0.000143	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—AKT2—breast cancer	3.08e-05	0.000142	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—FGFR1—breast cancer	3.07e-05	0.000141	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—CAV1—breast cancer	3.07e-05	0.000141	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—CXCL8—breast cancer	3.07e-05	0.000141	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—FGF10—breast cancer	3.06e-05	0.000141	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—HRAS—breast cancer	3.05e-05	0.00014	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—HIF1A—breast cancer	3.03e-05	0.000139	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—FGFR1—breast cancer	3.01e-05	0.000138	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—CDKN1B—breast cancer	3e-05	0.000138	CbGpPWpGaD
Naratriptan—HTR1F—GPCR downstream signaling—AKT1—breast cancer	2.97e-05	0.000136	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—HIF1A—breast cancer	2.96e-05	0.000136	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—PIK3CD—breast cancer	2.96e-05	0.000136	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PDGFA—breast cancer	2.96e-05	0.000136	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—LEP—breast cancer	2.95e-05	0.000136	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—CASP3—breast cancer	2.94e-05	0.000135	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—IL2—breast cancer	2.93e-05	0.000135	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CAV1—breast cancer	2.93e-05	0.000135	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—IL6—breast cancer	2.92e-05	0.000134	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—TGFBR2—breast cancer	2.91e-05	0.000134	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—KDR—breast cancer	2.89e-05	0.000133	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—LEP—breast cancer	2.89e-05	0.000133	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—ITPR1—breast cancer	2.87e-05	0.000132	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CAV1—breast cancer	2.87e-05	0.000132	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—CCND1—breast cancer	2.86e-05	0.000132	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—JUN—breast cancer	2.85e-05	0.000131	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—ERBB4—breast cancer	2.85e-05	0.000131	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—STAT5A—breast cancer	2.85e-05	0.000131	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—MMP3—breast cancer	2.85e-05	0.000131	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—PIK3CB—breast cancer	2.84e-05	0.000131	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—KDR—breast cancer	2.83e-05	0.00013	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—CTNNB1—breast cancer	2.83e-05	0.00013	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—ESR1—breast cancer	2.82e-05	0.00013	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—PIK3CG—breast cancer	2.8e-05	0.000129	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—FN1—breast cancer	2.79e-05	0.000128	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—MMP9—breast cancer	2.78e-05	0.000128	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—CDKN1A—breast cancer	2.77e-05	0.000127	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—ESR1—breast cancer	2.76e-05	0.000127	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—PTEN—breast cancer	2.76e-05	0.000127	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—SMAD4—breast cancer	2.76e-05	0.000127	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—NFKBIA—breast cancer	2.75e-05	0.000127	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—IGF1R—breast cancer	2.74e-05	0.000126	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—CXCL8—breast cancer	2.73e-05	0.000126	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—FN1—breast cancer	2.73e-05	0.000126	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—NOTCH1—breast cancer	2.73e-05	0.000125	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—MAPK8—breast cancer	2.7e-05	0.000124	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—NFKBIA—breast cancer	2.7e-05	0.000124	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—HES1—breast cancer	2.69e-05	0.000124	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—AKT1—breast cancer	2.69e-05	0.000124	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PLA2G4A—breast cancer	2.68e-05	0.000123	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—NCOR1—breast cancer	2.68e-05	0.000123	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—NOTCH1—breast cancer	2.67e-05	0.000123	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—PIK3CG—breast cancer	2.67e-05	0.000123	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—KIT—breast cancer	2.67e-05	0.000123	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—APC—breast cancer	2.67e-05	0.000123	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—FGF1—breast cancer	2.65e-05	0.000122	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CSF2—breast cancer	2.65e-05	0.000122	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—RAF1—breast cancer	2.64e-05	0.000122	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—EGF—breast cancer	2.63e-05	0.000121	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—NRG1—breast cancer	2.63e-05	0.000121	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—PIK3CG—breast cancer	2.61e-05	0.00012	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—APC—breast cancer	2.61e-05	0.00012	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—KIT—breast cancer	2.61e-05	0.00012	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—H2AFX—breast cancer	2.61e-05	0.00012	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—IL2—breast cancer	2.61e-05	0.00012	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—E2F1—breast cancer	2.59e-05	0.000119	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—EGF—breast cancer	2.58e-05	0.000119	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—PIK3CB—breast cancer	2.58e-05	0.000119	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—SRC—breast cancer	2.56e-05	0.000118	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—MAPK3—breast cancer	2.55e-05	0.000118	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—BRAF—breast cancer	2.51e-05	0.000115	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—MAPK3—breast cancer	2.5e-05	0.000115	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—VEGFA—breast cancer	2.49e-05	0.000115	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—SPP1—breast cancer	2.49e-05	0.000115	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—CXCL8—breast cancer	2.48e-05	0.000114	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—STAT3—breast cancer	2.47e-05	0.000114	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—ERBB3—breast cancer	2.46e-05	0.000113	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—PIK3CD—breast cancer	2.46e-05	0.000113	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—FGFR2—breast cancer	2.46e-05	0.000113	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—BRAF—breast cancer	2.45e-05	0.000113	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—IGF1—breast cancer	2.44e-05	0.000112	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—AKT2—breast cancer	2.44e-05	0.000112	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—EGFR—breast cancer	2.43e-05	0.000112	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—ALB—breast cancer	2.43e-05	0.000112	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—IGF1—breast cancer	2.39e-05	0.00011	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—AKT2—breast cancer	2.39e-05	0.00011	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—EGFR—breast cancer	2.38e-05	0.000109	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—IL2—breast cancer	2.37e-05	0.000109	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—TERT—breast cancer	2.36e-05	0.000109	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—MAPK3—breast cancer	2.36e-05	0.000109	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—PIK3CD—breast cancer	2.34e-05	0.000108	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—NOS3—breast cancer	2.32e-05	0.000107	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—PIK3CA—breast cancer	2.32e-05	0.000107	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—SERPINE1—breast cancer	2.32e-05	0.000107	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—PIK3CD—breast cancer	2.29e-05	0.000106	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—KRAS—breast cancer	2.29e-05	0.000106	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—MYC—breast cancer	2.29e-05	0.000106	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—FGFR1—breast cancer	2.29e-05	0.000105	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—TGFB1—breast cancer	2.29e-05	0.000105	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—PIK3CA—breast cancer	2.27e-05	0.000105	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—SERPINE1—breast cancer	2.27e-05	0.000104	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—HIF1A—breast cancer	2.26e-05	0.000104	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—KRAS—breast cancer	2.25e-05	0.000103	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—EGFR—breast cancer	2.24e-05	0.000103	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—NOS3—breast cancer	2.21e-05	0.000102	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—LEP—breast cancer	2.2e-05	0.000101	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CAV1—breast cancer	2.18e-05	0.0001	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—NOS3—breast cancer	2.17e-05	9.97e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—KDR—breast cancer	2.16e-05	9.94e-05	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—PIK3CB—breast cancer	2.14e-05	9.87e-05	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—PTGS2—breast cancer	2.12e-05	9.78e-05	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—KRAS—breast cancer	2.12e-05	9.76e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—PIK3CA—breast cancer	2.11e-05	9.7e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—ESR1—breast cancer	2.1e-05	9.68e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—MDM2—breast cancer	2.1e-05	9.66e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—RAF1—breast cancer	2.09e-05	9.63e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—RELA—breast cancer	2.08e-05	9.59e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—FN1—breast cancer	2.08e-05	9.56e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—ERBB2—breast cancer	2.07e-05	9.53e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—PIK3CA—breast cancer	2.06e-05	9.5e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—MDM2—breast cancer	2.06e-05	9.46e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—NFKBIA—breast cancer	2.05e-05	9.45e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—RAF1—breast cancer	2.05e-05	9.43e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—MTOR—breast cancer	2.04e-05	9.4e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—PIK3CB—breast cancer	2.04e-05	9.4e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—RELA—breast cancer	2.04e-05	9.39e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—NOTCH1—breast cancer	2.03e-05	9.36e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—ERBB2—breast cancer	2.03e-05	9.33e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—PIK3CB—breast cancer	2e-05	9.21e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—MTOR—breast cancer	2e-05	9.21e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—KIT—breast cancer	1.99e-05	9.15e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—APC—breast cancer	1.99e-05	9.15e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PIK3CG—breast cancer	1.99e-05	9.15e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—EGF—breast cancer	1.97e-05	9.05e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CXCL8—breast cancer	1.96e-05	9.03e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—HRAS—breast cancer	1.95e-05	8.98e-05	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—PIK3CA—breast cancer	1.95e-05	8.96e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CXCL8—breast cancer	1.92e-05	8.85e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CDKN1B—breast cancer	1.92e-05	8.82e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—HRAS—breast cancer	1.91e-05	8.79e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—MAPK3—breast cancer	1.9e-05	8.76e-05	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—AKT1—breast cancer	1.9e-05	8.73e-05	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—TP53—breast cancer	1.88e-05	8.67e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CASP3—breast cancer	1.88e-05	8.65e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CDKN1B—breast cancer	1.88e-05	8.64e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—IL2—breast cancer	1.88e-05	8.63e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—BRAF—breast cancer	1.87e-05	8.6e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—IL6—breast cancer	1.87e-05	8.59e-05	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—AKT1—breast cancer	1.86e-05	8.55e-05	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—PTEN—breast cancer	1.85e-05	8.53e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CASP3—breast cancer	1.84e-05	8.47e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—IL2—breast cancer	1.84e-05	8.45e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CCND1—breast cancer	1.83e-05	8.42e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—IL6—breast cancer	1.83e-05	8.41e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—JUN—breast cancer	1.82e-05	8.4e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—IGF1—breast cancer	1.82e-05	8.38e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—AKT2—breast cancer	1.82e-05	8.37e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—EGFR—breast cancer	1.81e-05	8.34e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CTNNB1—breast cancer	1.81e-05	8.34e-05	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—HRAS—breast cancer	1.8e-05	8.29e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CCND1—breast cancer	1.79e-05	8.24e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—JUN—breast cancer	1.79e-05	8.22e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—MMP9—breast cancer	1.78e-05	8.17e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CTNNB1—breast cancer	1.77e-05	8.16e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CDKN1A—breast cancer	1.77e-05	8.14e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—PTEN—breast cancer	1.76e-05	8.12e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PIK3CD—breast cancer	1.75e-05	8.05e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—MMP9—breast cancer	1.74e-05	8e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CDKN1A—breast cancer	1.73e-05	7.97e-05	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—PIK3CA—breast cancer	1.73e-05	7.97e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—SERPINE1—breast cancer	1.73e-05	7.96e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—PTEN—breast cancer	1.73e-05	7.95e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—MAPK8—breast cancer	1.73e-05	7.95e-05	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—IL6—breast cancer	1.72e-05	7.94e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—AKT1—breast cancer	1.72e-05	7.93e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—KRAS—breast cancer	1.71e-05	7.88e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—MAPK8—breast cancer	1.69e-05	7.78e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—AKT1—breast cancer	1.69e-05	7.76e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—NOS3—breast cancer	1.65e-05	7.6e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—SRC—breast cancer	1.64e-05	7.53e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—SRC—breast cancer	1.6e-05	7.38e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—VEGFA—breast cancer	1.59e-05	7.34e-05	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—AKT1—breast cancer	1.59e-05	7.32e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—STAT3—breast cancer	1.58e-05	7.27e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—PIK3CA—breast cancer	1.57e-05	7.24e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—MDM2—breast cancer	1.57e-05	7.21e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—VEGFA—breast cancer	1.56e-05	7.19e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—RAF1—breast cancer	1.56e-05	7.18e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—RELA—breast cancer	1.55e-05	7.15e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—STAT3—breast cancer	1.55e-05	7.11e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—ERBB2—breast cancer	1.54e-05	7.11e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—MTOR—breast cancer	1.52e-05	7.01e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PIK3CB—breast cancer	1.52e-05	7.01e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—MAPK3—breast cancer	1.51e-05	6.94e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—MAPK3—breast cancer	1.48e-05	6.8e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—MYC—breast cancer	1.47e-05	6.75e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CXCL8—breast cancer	1.46e-05	6.74e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—TGFB1—breast cancer	1.46e-05	6.74e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—HRAS—breast cancer	1.45e-05	6.7e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—MYC—breast cancer	1.44e-05	6.61e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—EGFR—breast cancer	1.43e-05	6.6e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—TGFB1—breast cancer	1.43e-05	6.59e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CDKN1B—breast cancer	1.43e-05	6.58e-05	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—AKT1—breast cancer	1.41e-05	6.51e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—EGFR—breast cancer	1.4e-05	6.47e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CASP3—breast cancer	1.4e-05	6.45e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—IL2—breast cancer	1.4e-05	6.44e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—IL6—breast cancer	1.39e-05	6.41e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CCND1—breast cancer	1.36e-05	6.28e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—JUN—breast cancer	1.36e-05	6.27e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—KRAS—breast cancer	1.36e-05	6.24e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CTNNB1—breast cancer	1.35e-05	6.22e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—KRAS—breast cancer	1.33e-05	6.11e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—MMP9—breast cancer	1.32e-05	6.1e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CDKN1A—breast cancer	1.32e-05	6.07e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PTEN—breast cancer	1.32e-05	6.06e-05	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—PIK3CA—breast cancer	1.31e-05	6.01e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—MAPK8—breast cancer	1.29e-05	5.93e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—AKT1—breast cancer	1.28e-05	5.91e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—PIK3CA—breast cancer	1.25e-05	5.73e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—SRC—breast cancer	1.22e-05	5.62e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—PIK3CA—breast cancer	1.22e-05	5.61e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—TP53—breast cancer	1.2e-05	5.54e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—VEGFA—breast cancer	1.19e-05	5.47e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—TP53—breast cancer	1.18e-05	5.43e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—STAT3—breast cancer	1.18e-05	5.42e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—HRAS—breast cancer	1.15e-05	5.3e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—HRAS—breast cancer	1.13e-05	5.19e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—MAPK3—breast cancer	1.12e-05	5.18e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—IL6—breast cancer	1.1e-05	5.08e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—MYC—breast cancer	1.09e-05	5.04e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—TGFB1—breast cancer	1.09e-05	5.02e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—IL6—breast cancer	1.08e-05	4.97e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—EGFR—breast cancer	1.07e-05	4.93e-05	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—AKT1—breast cancer	1.07e-05	4.91e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—AKT1—breast cancer	1.02e-05	4.68e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—KRAS—breast cancer	1.01e-05	4.65e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—AKT1—breast cancer	9.96e-06	4.58e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PIK3CA—breast cancer	9.29e-06	4.28e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—TP53—breast cancer	8.98e-06	4.14e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—HRAS—breast cancer	8.59e-06	3.96e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—IL6—breast cancer	8.22e-06	3.79e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—AKT1—breast cancer	7.59e-06	3.49e-05	CbGpPWpGaD
